Mountain Valley MD Holdings Inc.

Equities

MVMD

CA62430M1014

Pharmaceuticals

Market Closed - Canadian Securities Exchange 02:29:51 2024-04-26 pm EDT 5-day change 1st Jan Change
0.055 CAD 0.00% Intraday chart for Mountain Valley MD Holdings Inc. 0.00% +37.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Mountain Valley MD Holdings Inc. Plans to Introduce Soluvec 1% Coated Fish Feed in Bangladesh by May of 2024 CI
Mountain Valley MD Holdings Inc. Provides Update on Agrarius Trial Results CI
Mountain Valley MD Holdings Inc.?s Contracted Manufacturing Partner in the U.S. Completes the Set-Up and Testing of Equipment to Enable the Proprietary Production of Nutraceutical Applications for MVMD?s Quicksome Technology, Including Sublingual Rapid Dissolve Tablets and Powders CI
Mountain Valley MD Holdings Inc. Announces CFO Changes CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Mountain Valley Says Yong Yao to Take Role of CFO in January MT
Mountain Valley MD Holdings Inc. Announces CFO Changes Effective January 15, 2024 CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Mountain Valley Appoints New CFO MT
Mountain Valley MD Holdings Inc. Announces Chief Financial Officer Changes CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Mountain Valley MD Holdings Inc. Announces Publication of Soluvec Trial Data in Therapeutic Delivery CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Mountain Valley MD Holdings Inc. Enters into A License Agreement with Ontario Corporation for Its Soluvec™1% Animal Husbandry Applications for the Territory of the People's Republic of Bangladesh CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Mountain Valley MD Says Chief Medical Officer Transitioning to Advisory Role; Shares Down 15% MT
Mountain Valley Md Holdings Inc. Announces Transition of Azhar Rana, Chief Medical Officer to Advisory Role CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Mountain Valley MD Holdings Inc. Commences Commercial Sales of Agrarius, an Agro Plant Technology CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study for Soluvec™1% CI
Mountain Valley MD Holdings Inc. Appoints Elizabeth Norton to Advisory Role CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Mountain Valley MD Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Chart Mountain Valley MD Holdings Inc.
More charts
Mountain Valley MD Holdings Inc. is a Canada-based biotech company, which is focused on advancing solutions to optimize human, animal, and plant health. The Company is focused on implementation, licensing and reselling of key technologies and formulations, such as Quicksome oral formulation and delivery technologies, Quicksol solubility formulation technology, and Agrarius, a novel agricultural plant signaling technology. Quicksome technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats. Quicksol technology covers all solubilized macrocyclic lactones that could be applied in multiple viral applications that could impact human and animal health globally. Agrairus agricultural plant signaling technology is used as application to agricultural crops to naturally increase yields, reduce fertilizer usage, and enhance general resilience to pests and climate change.
More about the company